These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 1985948)

  • 1. Cyclosporin A slows collagen triple-helix formation in vivo: indirect evidence for a physiologic role of peptidyl-prolyl cis-trans-isomerase.
    Steinmann B; Bruckner P; Superti-Furga A
    J Biol Chem; 1991 Jan; 266(2):1299-303. PubMed ID: 1985948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins.
    Fischer G; Wittmann-Liebold B; Lang K; Kiefhaber T; Schmid FX
    Nature; 1989 Feb; 337(6206):476-8. PubMed ID: 2492638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin.
    Takahashi N; Hayano T; Suzuki M
    Nature; 1989 Feb; 337(6206):473-5. PubMed ID: 2644542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidyl-prolyl cis-trans isomerase activity as studied by dynamic proton NMR spectroscopy.
    Hübner D; Drakenberg T; Forsén S; Fischer G
    FEBS Lett; 1991 Jun; 284(1):79-81. PubMed ID: 2060630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of peptidyl-prolyl cis-trans isomerase on the in vitro folding of type III collagen.
    Bächinger HP
    J Biol Chem; 1987 Dec; 262(35):17144-8. PubMed ID: 3316229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermal stability and folding of type IV procollagen and effect of peptidyl-prolyl cis-trans-isomerase on the folding of the triple helix.
    Davis JM; Boswell BA; Bächinger HP
    J Biol Chem; 1989 May; 264(15):8956-62. PubMed ID: 2656691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes.
    Pyott SM; Schwarze U; Christiansen HE; Pepin MG; Leistritz DF; Dineen R; Harris C; Burton BK; Angle B; Kim K; Sussman MD; Weis M; Eyre DR; Russell DW; McCarthy KJ; Steiner RD; Byers PH
    Hum Mol Genet; 2011 Apr; 20(8):1595-609. PubMed ID: 21282188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional features of the peptidyl prolyl cis-trans isomerase, cyclophilin.
    Harding MW
    Pharmacotherapy; 1991; 11(6):142S-148S. PubMed ID: 1771139
    [No Abstract]   [Full Text] [Related]  

  • 9. Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts.
    Göthel SF; Marahiel MA
    Cell Mol Life Sci; 1999 Mar; 55(3):423-36. PubMed ID: 10228556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidyl-prolyl cis-trans isomerase improves the efficiency of protein disulfide isomerase as a catalyst of protein folding.
    Schönbrunner ER; Schmid FX
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4510-3. PubMed ID: 1584784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidyl-prolyl cis-trans isomerase from Bacillus subtilis. A prokaryotic enzyme that is highly sensitive to cyclosporin A.
    Herrler M; Bang H; Brune K; Fischer G; Marahiel MA
    FEBS Lett; 1992 Sep; 309(3):231-4. PubMed ID: 1516692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin A: new insights for cell biologists and biochemists.
    Hohman RJ; Hultsch T
    New Biol; 1990 Aug; 2(8):663-72. PubMed ID: 2282365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cyclophilin multigene family of peptidyl-prolyl isomerases. Characterization of three separate human isoforms.
    Bergsma DJ; Eder C; Gross M; Kersten H; Sylvester D; Appelbaum E; Cusimano D; Livi GP; McLaughlin MM; Kasyan K
    J Biol Chem; 1991 Dec; 266(34):23204-14. PubMed ID: 1744118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase.
    Halestrap AP; Davidson AM
    Biochem J; 1990 May; 268(1):153-60. PubMed ID: 2160810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.
    Bell A; Wernli B; Franklin RM
    Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-disulphide isomerase and prolyl isomerase act differently and independently as catalysts of protein folding.
    Lang K; Schmid FX
    Nature; 1988 Feb; 331(6155):453-5. PubMed ID: 3277061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel peptidyl-prolyl cis/trans isomerase from Escherichia coli.
    Rahfeld JU; Schierhorn A; Mann K; Fischer G
    FEBS Lett; 1994 Apr; 343(1):65-9. PubMed ID: 8163020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization of the prolyl 3-hydroxylase 1.cartilage-associated protein.cyclophilin B complex.
    Ishikawa Y; Wirz J; Vranka JA; Nagata K; Bächinger HP
    J Biol Chem; 2009 Jun; 284(26):17641-7. PubMed ID: 19419969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of immunosuppression by cyclosporins.
    Zenke G; Baumann G; Wenger R; Hiestand P; Quesniaux V; Andersen E; Schreier MH
    Ann N Y Acad Sci; 1993 Jun; 685():330-5. PubMed ID: 7689806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalysis of protein folding by cyclophilins from different species.
    Schönbrunner ER; Mayer S; Tropschug M; Fischer G; Takahashi N; Schmid FX
    J Biol Chem; 1991 Feb; 266(6):3630-5. PubMed ID: 1825312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.